Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Lenardo

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunityI J Fuss, W Strober, J K Dale, et al.
Novartis Foundation Symposium|October 7, 1998
Molecular genetic studies in lymphocyte apoptosis and human autoimmunityD A Martin, B Combadiere, F Hornung, et al.
Science (New York, N.Y.)|July 6, 2000
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutationsR M Siegel, J K Frederiksen, D A Zacharias, et al.
Cell|July 21, 1999
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type IIJ Wang, L Zheng, A Lobito, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2001
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesisJ J Bleesing, M R Brown, J K Dale, et al.
Science (New York, N.Y.)|April 24, 1999
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunityE M Schaeffer, J Debnath, G Yap, et al.
Blood|October 6, 2001
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndromeJ J Bleesing, M R Brown, S E Straus, et al.
Cell|June 16, 1995
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeG H Fisher, F J Rosenberg, S E Straus, et al.
The Journal of Pediatrics|November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosisA J Infante, H A Britton, T DeNapoli, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2015
Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 geneB N Chao, W H Baldwin, J F Healey, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1997
Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunityI J Fuss, W Strober, J K Dale, et al.
Novartis Foundation Symposium|October 7, 1998
Molecular genetic studies in lymphocyte apoptosis and human autoimmunityD A Martin, B Combadiere, F Hornung, et al.
Science (New York, N.Y.)|July 6, 2000
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutationsR M Siegel, J K Frederiksen, D A Zacharias, et al.
Cell|July 21, 1999
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type IIJ Wang, L Zheng, A Lobito, et al.
Clinical Immunology (Orlando, Fla.)|August 22, 2001
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesisJ J Bleesing, M R Brown, J K Dale, et al.
Science (New York, N.Y.)|April 24, 1999
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunityE M Schaeffer, J Debnath, G Yap, et al.
Blood|October 6, 2001
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndromeJ J Bleesing, M R Brown, S E Straus, et al.
Cell|June 16, 1995
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndromeG H Fisher, F J Rosenberg, S E Straus, et al.
The Journal of Pediatrics|November 20, 1998
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosisA J Infante, H A Britton, T DeNapoli, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2015
Characterization of a genetically engineered mouse model of hemophilia A with complete deletion of the F8 geneB N Chao, W H Baldwin, J F Healey, et al.
Pageof 9